Techstars Seed Funding and Early Investor Momentum

January 2, 2024

CranioSense secured $120,000 in seed funding from Techstars, adding a global innovation network to its roster of supporters.

This milestone was highlighted in our recent spotlight interview on Techstars’ channel, where we discussed our mission to advance noninvasive intracranial pressure (ICP) monitoring and the impact this technology could have on neuro-critical care.
Watch the full video: https://www.youtube.com/watch?v=GgcJ3GW4lcc

We’re also grateful for the continued support of Matt Kozlov, General Manager at Techstars HealthLA, whose leadership and insights have played a meaningful role in our journey.

The round was supported by experienced healthcare and technology investors who share our mission to transform the standard of care for ICP monitoring.